MAZE vs WRB · rev $20.0M vs P/E 17, rev $3.72B
Maze Therapeutics, Inc. Common Stock (MAZE) versus W. R. Berkley Corp (WRB) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
W. R. Berkley Corp (WRB) is a insurance - property & casualty company listed on US.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
Latest reported WRB revenue for 2026-06-30 was $3.72B. Net income was $452.3M. Revenue was up 0.7% from 2026-03-31 to 2026-06-30. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
MAZE currently screens at market cap $525.3M. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
Not investment advice. Open the MAZE and WRB stock pages for the full models.
Not investment advice.